LeadIQ logo
Learn more at LeadIQ.com
✕

Access Insights for Nuvation Bio and Millions of Other Companies

Sign up for full access to Nuvation Bio information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Insights

Acquisition of AnHeart Therapeutics Nuvation Bio's recent acquisition of AnHeart Therapeutics for $544 million positions the company as a key player in the development of precision cancer medicines, offering an opportunity to leverage the expertise and portfolio of novel therapeutic candidates.

Appointment of key personnel The strategic hiring of industry veterans like Colleen Sjogren as Chief Commercial Officer and Philippe Sauvage as Chief Financial Officer enhances Nuvation Bio's leadership team, creating potential collaboration opportunities and access to new networks for sales expansion.

FDA clearance for NUV-1511 The FDA clearance of the investigational new drug application for NUV-1511 opens up avenues for Nuvation Bio to explore partnerships with healthcare providers and institutions for the treatment of advanced solid tumors, paving the way for potential commercialization opportunities.

Strategic financing and funding Securing financing of $502 million and receiving investments like the $33,000 from Beacon Pointe Advisors LLC demonstrate investor confidence in Nuvation Bio's growth prospects, signaling a potential interest from stakeholders for partnership and investment opportunities.

Product updates for taletrectinib Nuvation Bio's launch of multiple updates for the taletrectinib program showcases the company's commitment to advancing innovative therapies in oncology, creating opportunities to engage with physicians, researchers, and stakeholders for clinical trials and adoption in the market.

Similar companies to Nuvation Bio

✕

Access Insights for Nuvation Bio and Millions of Other Companies

Sign up for full access to Nuvation Bio information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Nuvation Bio Tech Stack

Nuvation Bio uses 8 technology products and services including Alteryx, Cloudflare CDN, Typekit, and more. Explore Nuvation Bio's tech stack below.

  • Alteryx
    Advanced Analytics And Data Science
  • Cloudflare CDN
    Content Delivery Network
  • Typekit
    Font Scripts
  • Open Graph
    Miscellaneous
  • Webpack
    Miscellaneous
  • Office 365
    Office Suites
  • Microsoft Azure
    Platform As A Service
  • Python
    Programming Languages

Nuvation Bio's Email Address Formats

Nuvation Bio uses at least 1 format(s):
Nuvation Bio Email FormatsExamplePercentage
First.Last@nuvationbio.comJohn.Doe@nuvationbio.com
96%
F_Last@nuvationbio.comJ_Doe@nuvationbio.com
2%
Last_First@nuvationbio.comDoe_John@nuvationbio.com
1%
FirstLas@nuvationbio.comJohnDoe@nuvationbio.com
1%

Frequently Asked Questions

Where is Nuvation Bio's headquarters located?

Minus sign iconPlus sign iconNuvation Bio's main headquarters is located at 1500 Broadway STE: 1401 New York, NY 10036 US. The company has employees across 2 continents, including North AmericaAsia.

What is Nuvation Bio's stock symbol?

Minus sign iconPlus sign iconNuvation Bio is a publicly traded company; the company's stock symbol is NUVB.

What is Nuvation Bio's official website and social media links?

Minus sign iconPlus sign iconNuvation Bio's official website is nuvationbio.com and has social profiles on LinkedIn.

How much revenue does Nuvation Bio generate?

Minus sign iconPlus sign icon As of September 2024, Nuvation Bio's annual revenue reached $15M.

What is Nuvation Bio's NAICS code?

Minus sign iconPlus sign iconNuvation Bio's NAICS code is 3254 - Pharmaceutical and Medicine Manufacturing.

How many employees does Nuvation Bio have currently?

Minus sign iconPlus sign iconAs of September 2024, Nuvation Bio has approximately 114 employees across 2 continents, including North AmericaAsia. Key team members include Chief Technical Operations Officer: D. C. H.Chief People Officer: S. M.Chief Financial Officer: P. S.. Explore Nuvation Bio's employee directory with LeadIQ.

What industry does Nuvation Bio belong to?

Minus sign iconPlus sign iconNuvation Bio operates in the Pharmaceutical Manufacturing industry.

What technology does Nuvation Bio use?

Minus sign iconPlus sign iconNuvation Bio's tech stack includes AlteryxCloudflare CDNTypekitOpen GraphWebpackOffice 365Microsoft AzurePython.

What is Nuvation Bio's email format?

Minus sign iconPlus sign iconNuvation Bio's email format typically follows the pattern of . Find more Nuvation Bio email formats with LeadIQ.

How much funding has Nuvation Bio raised to date?

Minus sign iconPlus sign icon As of September 2024, Nuvation Bio has raised $502M in funding. The last funding round occurred on Feb 11, 2021 for $502M.

When was Nuvation Bio founded?

Minus sign iconPlus sign iconNuvation Bio was founded in 2018.
Nuvation Bio

Nuvation Bio

Pharmaceutical ManufacturingNew York, United States51-200 Employees

Nuvation Bio is a late-stage, global biopharmaceutical company tackling some of the greatest unmet needs in oncology by developing differentiated and novel therapeutic candidates. Nuvation Bio’s portfolio of development candidates includes taletrectinib (ROS1), safusidenib (mIDH1), NUV-868 (BET), and NUV-1511 (DDC). Nuvation Bio was founded in 2018 by biopharma industry veteran David Hung, M.D., who previously founded Medivation, Inc., which brought to patients one of the world’s leading prostate cancer medicines. Nuvation Bio has offices in New York, San Francisco, and Shanghai.

✕

Access Insights for Nuvation Bio and Millions of Other Companies

Sign up for full access to Nuvation Bio information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Section iconCompany Overview

Headquarters
1500 Broadway STE: 1401 New York, NY 10036 US
Website
nuvationbio.com
Stock Symbol
NUVB
NAICS Code
3254 - Pharmaceutical and Medicine Manufacturing
Founded
2018
Employees
51-200

Section iconMedia & News

Section iconFunding & Financials

  • $502M

    Nuvation Bio has raised a total of $502M of funding over 2 rounds. Their latest funding round was raised on Feb 11, 2021 in the amount of $502M.

  • $10M$50M

    Nuvation Bio's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $502M

    Nuvation Bio has raised a total of $502M of funding over 2 rounds. Their latest funding round was raised on Feb 11, 2021 in the amount of $502M.

  • $10M$50M

    Nuvation Bio's revenue is in the range of $10M$50M

Company Leadership

Employee Directory

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

✕

Access Insights for Nuvation Bio and Millions of Other Companies

Sign up for full access to Nuvation Bio information.
No credit card needed
OR
By creating an account, you agree to LeadIQ's Terms of Use and Privacy Policy.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.